Posthemorrhagic anemia: what it is and how it manifests itself

Posthemorrhagic anemia is a condition in which decreased hemoglobin levels and red blood cell counts occur due to blood loss. There are acute forms (following rapid and significant bleeding—trauma, surgery, gastrointestinal bleeding, postpartum hemorrhage) and chronic forms (prolonged minor blood loss—for example, during heavy menstruation or from ulcerative-erosive lesions of the gastrointestinal tract). The acute form is accompanied by a risk of shock and multiple organ failure, while the chronic form gradually leads to iron deficiency and a decrease in quality of life. [1]

From a clinical perspective, any rapid blood loss is dangerous because oxygen is transported by red blood cells, and a sharp reduction in their number impairs tissue oxygen supply. The body responds with compensatory tachycardia, vasoconstriction, and activated coagulation, but without treatment, this quickly wears off. Conversely, with slow, chronic blood loss, the blood becomes diluted, leading to iron deficiency, with characteristic symptoms such as weakness, shortness of breath during exertion, and pale skin and mucous membranes. [2]

In modern practice, outcome is influenced not only by the hemoglobin level, but also by the rate of decline, symptoms, and comorbidities. This is why the latest international guidelines for red blood cell transfusion emphasize individualization: they focus on hemoglobin thresholds and simultaneously consider clinical signs of tissue hypoxia and bleeding activity. This approach reduces unnecessary transfusions and improves safety. [3]

Acute posthemorrhagic anemia is a separate nosological entity in disease classification systems, while chronic posthemorrhagic anemia is considered iron deficiency anemia due to blood loss. This is important for proper coding, routing, and treatment planning (bleeding control, volume replenishment, correction of deficiencies, and prevention of recurrence). [4]

Code according to ICD-10 and ICD-11

In the International Classification of Diseases, Tenth Revision, acute posthemorrhagic anemia has a separate code, D62. This code is used for anemia following significant, rapid blood loss—trauma, surgery, massive gastrointestinal or obstetric hemorrhage. Chronic blood loss is coded as iron deficiency anemia due to blood loss—D50.0. The notes to D62 specifically state that anemia due to chronic blood loss is excluded and should be coded as D50.0. [5]

The International Classification of Diseases, Eleventh Revision, includes code 3A94 for "Acute posthemorrhagic anemia," while chronic posthemorrhagic anemia is classified under the section "Acquired iron deficiency anemia due to blood loss," which includes a separate code, 3A00.01 "Chronic posthemorrhagic anemia." ICD-11 utilizes post-coordination—codes can be supplemented with an indication of the cause (e.g., "postoperative bleeding," "gastrointestinal bleeding") and severity, which improves the accuracy of medical statistics. [6]

Table 1. Examples of coding for posthemorrhagic anemia

Clinical situation	ICD-10 (example)	ICD-11 (example)
Acute anemia after massive gastrointestinal bleeding	D62	3A94 + dilator "gastrointestinal bleeding"
Acute anemia after surgery/trauma	D62	3A94 + dilator "postoperative/traumatic"
Chronic blood loss (heavy menstruation, prolonged occult blood flow from the gastrointestinal tract)	D50.0	3A00.01 "Chronic posthemorrhagic anemia"
Unspecified anemia with suspected blood loss	D64.9 (temporary code pending clarification)	3A9Z (temporary code)
Sources: Official code browsers and manuals. [7]

Epidemiology

Posthemorrhagic anemia is a common consequence of acute and chronic blood loss. Acute gastrointestinal bleeding occurs at a rate of approximately 5-15 cases per 10,000 population per year; mortality from upper gastrointestinal bleeding reaches 3-14%, and from lower gastrointestinal bleeding, approximately 3%. A significant proportion of these patients present with anemia and require transfusion or iron replacement support. [8]

Postpartum hemorrhage remains the leading cause of maternal mortality worldwide, affecting millions of women annually and killing approximately 70,000 women. Even with a favorable outcome, severe anemia often develops, requiring targeted iron therapy and, if necessary, red blood cell transfusions. [9]

Chronic posthemorrhagic (iron deficiency) anemia is common in women of reproductive age due to menstrual losses and during pregnancy. The World Health Organization estimates that 30-40% of women aged 15-49 and pregnant women suffer from anemia; a significant proportion of cases are associated with blood loss and iron deficiency. [10]

In hospitals, acute anemia is one of the most common diagnoses for patients admitted for gastrointestinal bleeding. Research highlights the importance of not only transfusion but also subsequent diagnosis and treatment of iron deficiency, which, unfortunately, is often underestimated. This impacts recovery and the risk of rehospitalization. [11]

Table 2. Epidemiological landmarks

Indicator	Grade
Annual incidence of acute gastrointestinal bleeding	5-15 per 10,000
Mortality in upper gastrointestinal bleeding	3-14%
Mortality in lower gastrointestinal bleeding	≈3%
Women aged 15-49 years with anemia (world estimate)	≈31%
The leading global cause of postnatal mortality	Postpartum hemorrhage
Sources: WHO/GBD reviews and data. [12]

Reasons

Acute posthemorrhagic anemia develops with rapid blood loss: trauma with massive external bleeding, ruptured aneurysms, surgical complications, ulcerative and erosive lesions of the stomach and duodenum, esophageal varices, severe nosebleeds. Blood is lost rapidly, circulating blood volume decreases, and hemoglobin decreases as plasma is replenished. [13]

Chronic posthemorrhagic anemia is a consequence of prolonged, small blood losses. In women, this is most often due to heavy menstrual bleeding, while in men and older women, it is due to microbleeding from the gastrointestinal tract (polyps, tumors, angiodysplasia, ulcerative lesions, inflammatory bowel disease). Such losses deplete iron stores and lead to iron deficiency. [14]

Obstetric causes constitute a separate group: postpartum and postpartum periodic bleeding. Even without life-threatening complications, they often lead to moderate or severe anemia in the postpartum period, which impairs well-being and the ability to care for the child. Timely iron supplementation significantly accelerates recovery. [15]

Less common causes include hemorrhoidal bleeding, frequent blood donations without adequate iron replacement, and occult blood loss due to parasitic infestations and liver disease. In each case, it is important not only to treat the anemia but also to identify the source of the bleeding. [16]

Risk factors

For acute posthemorrhagic anemia, the depth and rate of blood loss are key factors. Risk factors include anticoagulants and antiplatelet agents, clotting disorders, liver disease, renal failure, advanced age, and the presence of central catheters or ulcerative lesions of the mucous membranes. These factors increase the likelihood of massive blood loss and complicate blood management. [17]

In chronic blood loss, risk factors include prolonged and heavy menstruation, pregnancy and breastfeeding, diets low in iron, inflammatory bowel disease, and the use of nonsteroidal anti-inflammatory drugs and glucocorticoids. In patients with liver disease, anemia is often associated with episodes of occult bleeding from varicose veins and gastropathy. [18]

The postpartum state itself is a risk for anemia: massive blood loss during childbirth, multiple pregnancies, uterine atony, placenta previa, and previous episodes of postpartum hemorrhage increase the likelihood of significant anemia after childbirth. It is important to plan for the prevention of iron deficiency and early monitoring of hemoglobin. [19]

In hospitals, the risks are compounded by frequent blood draws, multiple invasive procedures, and prolonged hospitalization with nutritional restrictions. A comprehensive "patient blood management" program helps mitigate these risks and reduce the need for transfusions. [20]

Pathogenesis

During acute blood loss, hemoglobin concentration may appear "normal" in the first hours because both plasma and cells are lost. As the blood volume is replenished with crystalloids and colloids, the blood "dilutes," and the true degree of anemia becomes apparent. Compensatory reactions, including tachycardia, peripheral vasoconstriction, and increased respiration, are simultaneously activated. [21]

Hormonal mechanisms, including activation of the renin-angiotensin-aldosterone system and the secretion of vasopressin, retain fluid to maintain blood pressure, further diluting the blood. In the following days, the bone marrow responds with reticulocytosis—the release of young red blood cells—if there is sufficient iron and vitamins. In chronic blood loss, this response breaks down due to depletion of iron stores. [22]

Iron deficiency with chronic iron loss develops gradually: first, ferritin reserves are depleted, then transferrin saturation decreases, and later, hemoglobin synthesis declines. Microcytosis and hypochromia of erythrocytes appear, oxygen transport is reduced, and tissue hypoxia develops, leading to fatigue and decreased performance. [23]

Thus, pathogenesis determines the strategy: in acute blood loss, first stop the bleeding and restore volume and oxygen transport; in chronic blood loss, eliminate the source and replenish iron until reserves are fully saturated. [24]

Symptoms

In the acute form, symptoms develop rapidly: weakness, dizziness, cold sweat, pallor, rapid pulse, drop in blood pressure, thirst, lethargy, and even fainting. Local signs depend on the source: bloody vomiting or tarry stools in upper gastrointestinal bleeding, scarlet stools in lower gastrointestinal bleeding, massive postpartum hemorrhage, and blood from a wound. [25]

In the chronic form, fatigue, decreased exercise tolerance, shortness of breath when climbing stairs, pallor, brittle nails, dry skin, cracks at the corners of the mouth, and sometimes taste perversion are prevalent. Often, the only clue is a gradual decrease in hemoglobin levels in tests without any obvious complaints. In such cases, a search for the source of blood loss is essential. [26]

In women of reproductive age, symptoms include heavy menstrual bleeding and headaches; after childbirth, severe weakness, dizziness upon standing, and difficulty lactating due to fatigue. In elderly patients, signs of anemia may be masked as "age-related fatigue" or manifest as worsening cardiovascular disease. [27]

It's important to remember that the severity of symptoms depends not only on the hemoglobin level but also on the rate of its decline. Rapid losses are more difficult to bear than a slow decline to the same level. This determines the emergency treatment strategy. [28]

Classification, forms and stages

Based on the time of development, acute posthemorrhagic anemia (hours to days after blood loss) and chronic posthemorrhagic anemia (weeks to months with prolonged losses) are distinguished. The acute form often requires resuscitation and transfusions, while the chronic form requires etiotropic treatment of the source and iron replacement therapy. [29]

Bleeding is classified by cause as traumatic, surgical, gastrointestinal, obstetric, and other. This classification helps guide the selection of diagnostic tools: for gastrointestinal bleeding—endoscopy; for obstetric bleeding—ultrasound and examination of the genital tract; for trauma—computed tomography with contrast or surgical exploration. [30]

Severity is determined based on the overall clinical picture: volume and rate of loss, blood pressure, pulse rate, level of consciousness, urine output, and laboratory parameters. In the chronic form, severity is determined by hemoglobin and the severity of iron deficiency, as well as the impact on daily activities. [31]

Table 3. Working classification of posthemorrhagic anemia

Base	Forms	Practical significance
Time	Acute / chronic	Urgency and priority of interventions
Source	Trauma, surgery, gastrointestinal tract, obstetrics, ENT, etc.	Selection of diagnostic methods
Heaviness	Mild, moderate, severe, shock	Treatment site and volume of transfusions
Sources: clinical reviews. [32]

Complications and consequences

Acute posthemorrhagic anemia can lead to hemorrhagic shock, acute renal failure, myocardial infarction due to oxygen deficiency, and death. The risk of complications increases with delays in stopping bleeding and late initiation of infusion and transfusion therapy. Rapid routing and "mass transfusion activation" protocols are lifesaving. [33]

The chronic form, if left untreated, perpetuates a vicious cycle of fatigue, cognitive decline, depression, and decreased performance. In pregnant women, anemia is associated with preterm birth, postpartum hemorrhage, and low birth weight. Iron supplementation improves outcomes for both mother and child. [34]

In patients with gastrointestinal bleeding, adverse outcomes are associated not only with the minimum hemoglobin level but also with the magnitude of its decline over a short period. This necessitates taking into account the dynamics of these indicators when planning transfusion and discharge strategies. [35]

Underestimation of iron deficiency after discharge leads to prolonged weakness and repeated hospitalizations. Research shows that iron supplementation after severe gastrointestinal bleeding is insufficient, despite being a direct way to speed recovery. [36]

When to see a doctor

Immediately - if there are signs of acute blood loss: vomiting "coffee grounds," black tarry stools or scarlet bleeding from the rectum, profuse postpartum bleeding, weakness with dizziness and cold sweat, a drop in blood pressure, or a rapid pulse. These conditions require an emergency call to an ambulance. [37]

Urgent treatment is indicated for progressive weakness, shortness of breath with normal activity, marked pallor, decreased exercise tolerance, and prolonged and heavy menstrual bleeding. It is important to quickly obtain a complete blood count and ferritin level to detect significant deficiency. [38]

Planned - for mild chronic fatigue with suspected iron deficiency, after gastrointestinal bleeding to monitor recovery and select iron replacement therapy, when taking non-steroidal anti-inflammatory drugs and anticoagulants. [39]

Pregnant and postpartum women should be treated at any sign of bleeding, dizziness upon standing, palpitations, or difficulty performing daily activities due to weakness. The sooner correction is started, the faster the recovery. [40]

Diagnostics

Step 1: Assess vital signs and stop bleeding. A complete blood count, blood type, and Rh factor are taken, a compatibility test is performed, and coagulation parameters and a biochemical profile are determined. In an acute situation, transfusion is not delayed until a full laboratory panel is completed, if indicated. [41]

Step 2. Find the source. For gastrointestinal bleeding, perform an urgent endoscopy; if trauma is suspected, perform a CT scan with contrast; in obstetrics, perform an examination and ultrasound. The choice of method is dictated by the clinic, but the principle is the same: confirm and eliminate the source. [42]

Step 3. Assess the degree of anemia and iron stores. In the acute phase, hemoglobin levels may lag behind reality due to hemodilution, so the test is repeated after stabilization. In the chronic phase, ferritin, transferrin saturation, serum iron, and reticulocytes are measured. Low ferritin confirms iron depletion. [43]

Step 4. Plan treatment and subsequent management. For the acute form, this includes a massive transfusion protocol if necessary, hemostatic therapy, and endoscopic or surgical methods to stop bleeding. For the chronic form, this includes identifying and treating the underlying cause, plus oral or intravenous iron replacement therapy. [44]

Table 4. Diagnostic matrix for suspected posthemorrhagic anemia

Target	What to do immediately	What needs to be clarified further?
Confirm anemia and safety of transfusion	Complete blood count, blood type and Rh factor, coagulogram	Repeat hemoglobin after volume stabilization
Find the source of bleeding	Endoscopy/CT/ultrasound as indicated	Blood loss balance and hemostasis plan
Assess your iron status	Ferritin, transferrin saturation	Iron replacement therapy plan
Sources: reviews and guides. [45]

Differential diagnosis

Hemolytic anemia: with hemolysis, hemoglobin drops without blood loss, characterized by elevated bilirubin, lactate dehydrogenase, and decreased haptoglobin; urine may darken, and the spleen may enlarge. In posthemorrhagic anemia, the key is the fact of blood loss and the absence of biochemical markers of hemolysis. [46]

In anemia of chronic diseases, iron is "locked" in depots by inflammation, ferritin is elevated or normal, and transferrin saturation is moderately reduced. In chronic posthemorrhagic anemia, ferritin is reduced and the microscopic appearance of red blood cells is typical of iron deficiency (microcytosis and hypochromia). [47]

Aplastic and infiltrative processes in the bone marrow: in addition to anemia, thrombocytopenia and leukopenia are present, and in bone marrow aspirate, hypocellularity or replacement by tumor cells. A rapid oncohematological consultation and a different treatment plan are important here. [48]

For functional "dilution" anemia after massive infusions: temporary hemodilution without significant blood loss. The solution is provided by the overall clinical picture: there are no signs of active bleeding, the hemodynamic profile is stable, and ferritin levels are often normal. [49]

Treatment

The first principle in acute posthemorrhagic anemia is controlling the bleeding source. Endoscopic coagulation, clipping, and adrenaline injection for gastrointestinal bleeding, surgical hemostasis for trauma, and obstetric interventions for postpartum hemorrhage—the choice is dictated by the location. Without reliable hemostasis, transfusions and infusions will only provide a temporary effect. [50]

The second principle is restoring circulating blood volume and maintaining perfusion of vital organs. Crystalloids are used, colloids when indicated, and early red blood cell transfusion is performed using a massive transfusion protocol, which also includes fresh frozen plasma and platelets in cases of coagulopathy and massive blood loss. The goal is to stabilize blood pressure, pulse rate, and urine output. [51]

Red blood cell transfusions are administered based on thresholds and symptoms. Current international guidelines from 2023 support a "restrictive" strategy for most stable patients: the benchmark is hemoglobin below 7 g/dL, and in cardiovascular disease, closer to 8 g/dL or in the presence of hypoxic symptoms. However, if bleeding continues, shock, or signs of myocardial ischemia are present, transfusions are administered earlier, based on clinical findings. [52]

Hemostatic drug support includes acid inhibitors (e.g., for ulcer bleeding), adjustment of anticoagulants, use of tranexamic acid in certain scenarios, and treatment of causative factors (e.g., eradication of Helicobacter pylori after an ulcer episode). Teamwork between a gastroenterologist, surgeon, anesthesiologist, and hematologist accelerates control. [53]

After stabilization, all patients with iron deficiency are recommended iron replacement therapy to "close the deficit" and replenish iron stores. Oral iron supplements are suitable for most patients, but after severe gastrointestinal bleeding or in cases of intolerance to oral forms, intravenous iron is preferable, as it more quickly restores hemoglobin and ferritin stores. A treatment plan and ferritin monitoring are discussed in advance. [54]

For chronic posthemorrhagic anemia, treatment is two-stage: eliminating the cause (treatment of menorrhagia, endoscopic treatment of bleeding lesions, discontinuation of nonsteroidal anti-inflammatory drugs that are harmful to the mucosa) and iron replacement. The goal is not only to normalize hemoglobin but also to achieve a ferritin level of at least 50-100 ng/ml to restore tissue reserves. This reduces the risk of anemia recurrence. [55]

In pregnant women and in the postpartum period, the strategy is based on safe correction: for moderate anemia, oral iron with tolerance monitoring; for severe anemia, intravenous iron preparations. Red blood cell transfusion is indicated for severe symptomatic anemia or ongoing bleeding. At the same time, obstetric causes are eliminated and prophylaxis is planned for the following period. [56]

Discharge after acute gastrointestinal bleeding should be accompanied by a plan: iron (oral or intravenous), ferritin monitoring after 4-8 weeks, Helicobacter pylori testing and eradication if detected, and repeat endoscopy if indicated. This approach reduces recovery time and the number of readmissions, as confirmed by observational studies. [57]

Patient-centered blood management programs help reduce unnecessary transfusions and improve outcomes: early screening and correction of anemia before surgery, economical blood sampling, and the use of local hemostatic technologies. These principles are being implemented in surgery, obstetrics, and oncology and are formalized in modern guidelines. [58]

Particular attention is given to patients with concomitant coronary artery disease and older age groups. For them, transfusion thresholds may be higher, and monitoring more intensive. Together with a cardiologist, assess signs of ischemia, heart rate, and blood pressure, and make transfusion decisions based not only on hemoglobin levels but also on clinical findings. [59]

Table 5. Rapid guidelines for transfusion tactics (adults, in the absence of active bleeding)

Scenario	Hemoglobin landmark	Comment
Most stable patients	< 7 g/dL	Consider symptoms, rate of decline, comorbidities
Cardiovascular diseases, old age	≈ 8 g/dL	Individualize according to the ischemia clinic
Ongoing bleeding/shock	Around the clinic	Transfuse earlier, following the massive transfusion protocol
Sources: 2023 International Guidelines on Blood Transfusion. [60]

Prevention

Primary prevention of acute posthemorrhagic anemia involves bleeding prevention: safe surgical and endoscopic techniques, correction of coagulopathies before interventions, cautious use of nonsteroidal anti-inflammatory drugs and anticoagulants according to strict indications. Patients with ulcers are recommended eradication of Helicobacter pylori and maintenance antiulcer therapy. [61]

Prevention of chronic posthemorrhagic anemia includes treatment of menorrhagia, control of gastrointestinal bleeding, and a diet containing sufficient iron and vitamin C to improve absorption. For women of reproductive age and pregnant women, the World Health Organization recommends prophylactic iron supplementation of 30-60 mg of elemental iron per day in vulnerable groups. [62]

In hospitals, protocols for "careful" blood handling are useful: minimizing blood draw volumes, using pediatric tubes, electronic prompts for transfusion thresholds, and staff training. This reduces the incidence of iatrogenic anemia and the need for transfusions. [63]

Table 6. For whom iron deficiency prevention is especially important

Group	Recommendations
Women with heavy menstrual periods	Examination, treatment of menorrhagia, ferritin monitoring
Pregnant and postpartum period	Preventive iron, early screening for anemia
Patients with peptic ulcer and NSAIDs	Mucosal protection therapy, Helicobacter pylori eradication
Elderly patients on anticoagulants	Regular blood and stool testing for occult blood
Sources: WHO, clinical reviews. [64]

Forecast

The prognosis for acute posthemorrhagic anemia depends on the speed of bleeding control and the initiation of infusion and transfusion therapy. Mortality rates for upper gastrointestinal bleeding range from 3-14% and are determined by the severity of the underlying condition, age, and the timeliness of treatment. Coordinated multidisciplinary teamwork improves outcomes. [65]

In chronic posthemorrhagic anemia, the prognosis is favorable if the source is eliminated and iron stores are fully replenished. Untreated deficiency leads to prolonged symptoms and decreased performance, especially in women of reproductive age and elderly patients. Regular monitoring of ferritin reduces the risk of relapse. [66]

After discharge from the hospital, "bridges" to outpatient care are important: iron therapy plan, follow-up tests, and, if necessary, repeat endoscopy. Research shows that such connectivity reduces the frequency of readmissions and accelerates recovery. [67]

Globally, the burden of anaemia remains high, particularly in women and children; efforts to prevent iron deficiency and improve the quality of surgical and obstetric care are gradually reducing premature mortality and disability. [68]

FAQ

What is the difference between acute posthemorrhagic anemia and chronic anemia? Acute anemia is characterized by rapid and significant blood loss with the risk of shock and an urgent need for transfusion. Chronic anemia is characterized by prolonged, small losses that lead to iron deficiency and gradual fatigue. Treatment and urgency vary. [69]

Is blood always transfused for acute anemia? No. The decision depends on the hemoglobin level, symptoms, and rate of blood loss. Current guidelines support a "restrictive" strategy for stable patients, but with ongoing bleeding, shock, or signs of ischemia, transfusion is given earlier. [70]

How long should iron be taken for chronic posthemorrhagic anemia? Until hemoglobin levels are normalized and iron stores are reached: the goal is a ferritin level of at least 50-100 ng/ml. This is often 2-3 months or more; the exact duration is determined by the doctor based on follow-up tests. [71]

If hemoglobin is "normal," can anemia occur after bleeding? In the first hours after acute blood loss, hemoglobin may be falsely "normal" due to the simultaneous loss of plasma. As infusions progress, the blood dilutes, and anemia develops. Therefore, tests are repeated after stabilization. [72]

What are the signs of dangerous gastrointestinal bleeding? Vomiting "coffee grounds," black, tarry stools, scarlet rectal bleeding, severe weakness, and dizziness. These are all signs that call for immediate medical attention. [73]

Additional tables

Table 7. Causes and key treatment approaches

Cause	Examples	The key to healing
Gastrointestinal	Ulcers, erosions, varicose veins, angiodysplasia	Endoscopic hemostasis, acid inhibitors, Helicobacter pylori eradication
Obstetrics	Uterine atony, placenta previa	Obstetric hemostasis, infusions, iron/transfusion as indicated
Trauma/surgery	Vascular injury, postoperative fistula	Surgical hemostasis, massive transfusion protocol
Chronic low losses	Menorrhagia, occult bleeding	Etiotropic treatment of the source, iron replacement therapy
Sources: clinical reviews and guidelines. [74]